(2021). Safety of B-blockers in Patients with Chronic Hepatitis C under Treatment with sofosbuvir and Daclatasvir. Aswan University Medical Journal, 1(1), 58-68. doi: 10.21608/aumj.2021.227984
MLA
. "Safety of B-blockers in Patients with Chronic Hepatitis C under Treatment with sofosbuvir and Daclatasvir", Aswan University Medical Journal, 1, 1, 2021, 58-68. doi: 10.21608/aumj.2021.227984
HARVARD
(2021). 'Safety of B-blockers in Patients with Chronic Hepatitis C under Treatment with sofosbuvir and Daclatasvir', Aswan University Medical Journal, 1(1), pp. 58-68. doi: 10.21608/aumj.2021.227984
VANCOUVER
Safety of B-blockers in Patients with Chronic Hepatitis C under Treatment with sofosbuvir and Daclatasvir. Aswan University Medical Journal, 2021; 1(1): 58-68. doi: 10.21608/aumj.2021.227984
)
View on SCiNiTO